Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qinxiang Qingjie Oral Liquid for pediatric acute upper respiratory infection (heat in exterior and interior syndrome)
ChiCTR2200056105Phase 3Completed
- Sponsor
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
- Start
- May 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of Qinxiang Qingjie Oral Liquid in upper respiratory infection (URI) (2 arms), sponsored by First Teaching Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoints: Disease curative effect, TCM syndrome changes and 1 more. Started May 2005; status: completed.
02
Drugs
Qinxiang Qingjie Oral Liquid
03
Conditions
upper respiratory infection (URI)
Beyond the preview
Go deeper on ChiCTR2200056105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200056105.